XML 67 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
Operating Segments (Tables)
9 Months Ended
Sep. 30, 2012
Reportable Segments Summarized Financial Information

Summarized financial information concerning our reportable segments is shown in the following table. Corporate & other includes corporate-related items not allocated to the reportable segments.

 

     Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
     2012     2011     2012     2011  
     (In thousands)  

Net sales:

        

Polymer Solutions

   $ 216,992      $ 243,931      $ 692,139      $ 792,604   

Catalysts

     251,201        299,531        773,867        827,339   

Fine Chemistry

     193,033        179,515        591,818        541,672   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total net sales

   $ 661,226      $ 722,977      $ 2,057,824      $ 2,161,615   
  

 

 

   

 

 

   

 

 

   

 

 

 

Segment operating profit:

        

Polymer Solutions

   $ 42,964      $ 55,219      $ 157,487      $ 203,900   

Catalysts

     53,937        93,682        185,656        209,251   

Fine Chemistry

     46,036        34,793        135,543        111,387   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total segment operating profit

     142,937        183,694        478,686        524,538   
  

 

 

   

 

 

   

 

 

   

 

 

 

Equity in net income of unconsolidated investments:

        

Polymer Solutions

     1,199        1,357        4,957        6,496   

Catalysts

     6,736        8,170        24,276        30,796   

Fine Chemistry

     —          —          —          —     

Corporate & other

     —          (27     —          (174
  

 

 

   

 

 

   

 

 

   

 

 

 

Total equity in net income of unconsolidated investments

     7,935        9,500        29,233        37,118   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net (income) loss attributable to noncontrolling interests:

        

Polymer Solutions

     (602     (2,021     (1,255     (9,200

Catalysts

     —          —          —          —     

Fine Chemistry

     (4,373     (4,789     (11,577     (14,439

Corporate & other

     —          (50     (20     57   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total net income attributable to noncontrolling interests

     (4,975     (6,860     (12,852     (23,582
  

 

 

   

 

 

   

 

 

   

 

 

 

Segment income:

        

Polymer Solutions

     43,561        54,555        161,189        201,196   

Catalysts

     60,673        101,852        209,932        240,047   

Fine Chemistry

     41,663        30,004        123,966        96,948   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total segment income

     145,897        186,411        495,087        538,191   

Corporate & other(a)

     (7,993     (23,462     (48,466     (72,889

Restructuring and other charges(b)

     (6,508     —          (101,211     —     

Interest and financing expenses

     (7,914     (9,710     (25,134     (28,576

Other income, net

     2,370        956        1,564        534   

Income tax expense(c)

     (26,591     (38,097     (76,804     (100,423
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income attributable to Albemarle Corporation

   $ 99,261      $ 116,098      $ 245,036      $ 336,837   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) Corporate and other charges for the three-month and nine-month periods ended September 30, 2012 include reductions in performance-based incentive compensation accruals comprised of approximately $5.4 million in adjustments based on current estimates of related performance achievement measures and approximately $2.2 million in adjustments associated with forfeitures from employee departures. These items are reflected primarily in Selling, general and administrative expenses in our consolidated statements of income.
(b) The three-month and nine-month periods ended September 30, 2012 include a settlement charge of $6.5 million ($4.1 million after income taxes) associated with our SERP in connection with the retirement of our former CEO and executive chairman. The nine-month period ended September 30, 2012 also includes charges amounting to $94.7 million ($73.6 million after income taxes) in connection with our exit of the phosphorous flame retardants business.
(c) The three-month and nine-month periods ended September 30, 2012 includes $4.5 million of net tax benefits related principally to the release of various tax reserves for uncertain domestic tax positions due to the expiration of the statute of limitations related to the 2008 tax year.